Theme

Think before you buy

See our new campaign about how to protect yourself when buying medicines – whether at the pharmacy, in retail stores, or online.

Go to theme
Theme

Strategy for the DKMA

The Danish Medicines Agency has formulated a strategy for 2022-26. The strategy emphasizes a vision of leading the way in national and international cooperation, and in the dialogue with citizens and society. Read more.

Go to theme
indgangsikon nr 1

General public

Here you can read about reimbursement, drugs affecting the ability to drive and other topics relevant for the general public.

indgangsikon nr 2

Industry

Information on licensing, inspections, fees, company authorisations, clinical trials and more.

indgangsikon nr 3

Healthcare professionals

This section gathers information for doctors, nurses, pharmacies, dentists and other healthcare professionals.

News

PRAC assesses that NAION could be a very rare side effect of Ozempic, Rybelsus and Wegovy

19 March 2026

EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) recommends that the product information for semaglutide medicines should include information that the rare eye condition NAION could be a very rare side effect. Treatment should be stopped if symptoms of NAION occur.

For Clinical Trials with ATMP: Guidance to the content of the Investigator´s Brochure published

06 March 2026

New functionalities in the CTIS-module Non-substantial modification

09 February 2026

Electronic dispatch of decision letters marks its fifth anniversary

04 February 2026